1 terminated. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Rifaximin delayed released 400mg Tablet: new trials by email Literature Review of Rifaximin delayed released 400mg Tablet trials Research Report on Rifaximin delayed released 400mg Tablet
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rifaximin Delayed Release for the Prevention of Recurrent Acute Diverticulitis and Diverticular Complications. Rifaximin delayed released 400mg Tablet, Placebo - Diverticulitis | Phase 2 / Phase 3 | Terminated | Alfasigma S.p.A. | 193 | 2018-07-02 | 2021-10-20 |
Diverticulitis (1)
Alfasigma S.p.A. (1)
France (1) · Germany (1) · Italy (1) · Netherlands (1) · Spain (1) · United Kingdom (1)
2017 (1)